AI
Alphabet Inc Portfolio holdings
AUM
$2.14B
This Quarter Return
-14.81%
1 Year Return
+56.95%
3 Year Return
+189.16%
5 Year Return
+193.61%
10 Year Return
+303.91%
AUM
$4.14B
AUM Growth
+$4.14B
(-1.7%)
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
25.48%
Top 10 Holdings %
Top 10 Hldgs %
76.41%
Holding
58
New
15
Increased
–
Reduced
10
Closed
–
Top Buys
| 1 |
IonQ
IONQ
|
$366M |
| 2 |
Toast
TOST
|
$330M |
| 3 |
EQRX
EQRx, Inc. Common Stock
EQRX
|
$324M |
| 4 |
Planet Labs
PL
|
$196M |
| 5 |
Freshworks
FRSH
|
$106M |
Top Sells
| 1 |
UiPath
PATH
|
$152M |
| 2 |
Arcus Biosciences
RCUS
|
$62.2M |
| 3 |
Duolingo
DUOL
|
$60.3M |
| 4 |
DexCom
DXCM
|
$54.6M |
| 5 |
Robinhood
HOOD
|
$49.2M |
Sector Composition
| 1 | Healthcare | 47.14% |
| 2 | Technology | 41.19% |
| 3 | Industrials | 6.55% |
| 4 | Consumer Staples | 2.6% |
| 5 | Financials | 2.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
UiPath
PATH
$5.95B
| $607M | 14.65% | 14,068,674 -3,512,754 | -20% | -$152M |
|
|
VERV
2
DELISTED
Verve Therapeutics
VERV
| $405M | 9.77% | 10,974,011 | – | – |
|
|
3
DexCom
DXCM
$29.5B
| $378M | 9.13% | 704,011 -101,670 | -13% | -$54.6M |
|
|
4
IonQ
IONQ
$12.7B
| $366M | 8.83% | +21,907,038 | New | +$366M |
|
|
5
Toast
TOST
$26.3B
| $330M | 7.96% | +9,496,884 | New | +$330M |
|
|
EQRX
6
DELISTED
EQRx, Inc. Common Stock
EQRX
| $324M | 7.83% | +47,552,687 | New | +$324M |
|
7
Lyft
LYFT
$6.73B
| $262M | 6.33% | 6,138,154 | – | – |
|
|
8
Planet Labs
PL
$2.15B
| $196M | 4.74% | +31,942,641 | New | +$196M |
|
9
Oscar Health
OSCR
$4.31B
| $189M | 4.56% | 24,042,864 | – | – |
|
|
BHIL
10
DELISTED
Benson Hill, Inc.
BHIL
| $108M | 2.6% | 14,752,271 | – | – |
|
|
11
Freshworks
FRSH
$3.93B
| $106M | 2.56% | +4,035,595 | New | +$106M |
|
|
12
Arcus Biosciences
RCUS
$1.13B
| $104M | 2.51% | 2,563,441 -1,537,034 | -37% | -$62.2M |
|
|
13
Robinhood
HOOD
$92.4B
| $87.5M | 2.11% | 4,928,535 -2,768,800 | -36% | -$49.2M |
|
|
DM
14
DELISTED
Desktop Metal, Inc.
DM
| $54.7M | 1.32% | 11,048,730 | – | – |
|
15
Relay Therapeutics
RLAY
$619M
| $48M | 1.16% | 1,564,173 -77,324 | -5% | -$2.37M |
|
16
Lyell Immunopharma
LYEL
$213M
| $45.4M | 1.1% | 5,865,125 | – | – |
|
|
ME
17
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $44.9M | 1.08% | +6,736,785 | New | +$44.9M |
|
18
Sana Biotechnology
SANA
$777M
| $43.5M | 1.05% | 2,812,500 | – | – |
|
19
Invivyd
IVVD
$204M
| $41.2M | 1% | 5,680,785 | – | – |
|
|
SNCE
20
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $40.4M | 0.98% | +3,241,075 | New | +$40.4M |
|
21
Monte Rosa Therapeutics
GLUE
$296M
| $29.9M | 0.72% | 1,464,015 | – | – |
|
22
Beam Therapeutics
BEAM
$1.66B
| $25.6M | 0.62% | 321,604 | – | – |
|
23
RAPT Therapeutics
RAPT
$188M
| $23.1M | 0.56% | 627,762 -82,488 | -12% | -$3.03M |
|
24
Illumina
ILMN
$15.8B
| $20.3M | 0.49% | 53,470 | – | – |
|
|
ENJY
25
DELISTED
Enjoy Technology, Inc. Common Stock
ENJY
| $20.1M | 0.48% | +4,345,340 | New | +$20.1M |
|